Pain relief with BUPIVACAINE after cholecystectomy

Postoperative pain relief with intraperitoneal bupivacaine after laparoscopic cholecystectomy - NIL

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070462

Enrollment

Registered

2024-07-11

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Intraperitoneal instillation of BUPIVACAINE: Patients undergoing laparoscopic cholecystectomy in test group will receive 20 ml of 0.25% BUPIVACAINE administered via cannula into the re

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing laparoscopic cholecystectomy

Exclusion criteria

Exclusion criteria: 1. Known allergy to local anaesthetics. 2. Known cardiac issues. 3. Procedures converted to open cholecystectomy. 4. Patients who do not consent. 5. Patients with acute cholecystitis. 6. Patients undergoing interval cholecystectomy.

Design outcomes

Primary

Measure	Time frame
Postoperative pain score by visual analogue pain scale Timepoint: 0,2,4,6 hours postoperatively	—

Secondary

Measure	Time frame
Analgesic usage Time taken to start mobilizing Duration of hospital stayTimepoint: 24 hours and at discharge	—

Countries

India

Contacts

Public ContactSatya

SRI RAMACHANDRA INSTITUTE OF HIGHER EDUCATION AND RESEARCH

rajasenthilv@gmail.com9442569625

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026